-+ 0.00%
-+ 0.00%
-+ 0.00%

Ensemble VC backs Neion Bio, which engineers chickens to produce therapeutic proteins in eggs

PUBT·08/12/2026 19:27:02
Listen to the news
Ensemble VC backs Neion Bio, which engineers chickens to produce therapeutic proteins in eggs
  • Ensemble VC highlighted portfolio company Neion Bio’s platform to produce therapeutic proteins in genetically engineered chicken eggs.
  • Strategy targets lower-cost, faster-to-scale biologics manufacturing by expanding flocks rather than building CHO-based bioreactor facilities.
  • Initial pipeline focuses on biosimilars for biologic drugs expected to lose patent protection over the next decade.
  • Update published Aug. 12, 2026; Neion Bio is positioned as a manufacturing-layer partner for biotech and pharma drug development.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ensemble VC Management LLC published the original content used to generate this news brief on August 12, 2026, and is solely responsible for the information contained therein.